Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: BaNosser, I'm sure pubpat was not around in 1989 EHWEST:
8
Nov 04, 2007 05:16PM
1
Nov 04, 2007 06:51PM
5
Nov 05, 2007 01:55AM

Nov 05, 2007 04:15AM
1
Nov 05, 2007 04:34AM

Nov 05, 2007 05:31AM

http://www.agoracom.com/ir/patriot/m...

Re: Can we ASSUME (NEC brought Ledzius before PUBPAT did)

Posted by: DDiligen on February 08, 2007 04:06PM

In response to: Can we ASSUME by optymystic

With the bailout of NEC, the PUBPAT issue is carrying much less weight now.
Some prior art brought out by PUBPAT was not new, since NEC and Toshiba
already presented in their requests before PUBPAT did. The exaple I found is the
reference to Ledzius, which is the heavyly cited reference in PUBPAT
request. Three out 5 items (E to I) cited Ledzius as shown below -
=================
A. Introduction...........................
B. Summary of the Law Governing Reexamination......1
C. Subject Matter Background of the '336 Patent..........2
D. Notice of Pending Litigation Involving the '336 Patent....3
E. A substantial new question of patentability as to claims 110
is raised by Ledzius in light of Mostek, as further
evidenced by prior prosecution correspondences, Paper 6 and Paper 12. ....4
F. A substantial new question of patentability as to claims 110 is raised by
Mostek.... ..........................5
G. A substantial new question of patentability as to claims 110 is raised by
Ledzius in light of Guttag.............. ..........................5
H. A substantial new question of patentability as to claims 110 is raised by
Ledzius in light of Thaden.... ..............................6
I. A substantial new question of patentability as to claims 15 is raised by
Hitachi in light of Boney...... .................................7
=================


Another point is that examinner centainly will treat the bailout of NEC as a factor in
favor of the patent hold in patent validity considerations during reexamination process.

DD

--------

Thank you DDilligen

Share
New Message
Please login to post a reply